Florian Foeger
Chief Executive Officer Cyprumed
Florian Foeger is the founder and CEO of Cyprumed GmbH an oral peptide delivery company. Previously, Florian was the Director or Oral Formulation Research at Novo Nordisk.
Seminars
Wednesday 29th April 2026
Oral Formulations for Macrocyclic Peptides & Linear GLP-1 Peptides
1:30 pm
- Highlighting the impact of gastrointestinal targeting
- Improving oral bioavailability across the gut
- Strategies to reduce negative food impact
NEW COMPANY
Wednesday 29th April 2026
Fireside Peptide Delivery Discussion – Pushing the Limits of Peptide Formulation & Delivery from Novel Design to Effective Targeting Strategies for Better Patient Outcomes
3:30 pm
- How to effectively design patient-centric peptide delivery formulations (oral vs injectable)?
- How to ensure novel peptide formulations can be scalable and cost efficient during the manufacturing process?
- Where will delivery innovations take the peptide field in the next 5 years?
